Development of geriatric syndromes after taking countermeasures for polypharmacy: An overlooked issue of quitting semiregular single-dose medicine

0Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report a case of an elderly woman on polypharmacy who developed appetite loss, general fatigue and muscle weakness mainly from secondary adrenal insufficiency caused by quitting one semiregular single-dose medicine. Because the degree of insufficiency was mild, her symptoms were eliminated after some time without additional treatment. The present case includes important lessons related to medication management in elderly patients. Additionally, the present case also warns us to be cautious while diagnosing geriatric syndromes as a part of the physiological aging process or additional disease symptoms. Drug-induced geriatric syndrome from quitting semiregular-use drugs should be investigated in future studies.

Cite

CITATION STYLE

APA

Tomita, N., Ishiki, A., Okinaga, S., Furukawa, K., & Arai, H. (2019). Development of geriatric syndromes after taking countermeasures for polypharmacy: An overlooked issue of quitting semiregular single-dose medicine. Oxford Medical Case Reports, 2019(6), 259–261. https://doi.org/10.1093/omcr/omz047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free